Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in western Mexico

Abstract

Background The study of stool microbiota has taken great relevance in the last years, given its role in the maintenance of the intestinal metabolic, physiological, and immunological homeostasis, as well as, its effect over HIV biomarkers levels such as CD4/CD8 ratio, high sensitivity C-Reactive Protein (hs-CRP), related to poor outcomes (rapid progression to AIDS). Several efforts have been made to characterize the gut microbiome. In HIV infection, most of the studies report the presence of a dysbiotic pattern; however, few of them have made an approach in elderly HIV-positive subjects despite the fact that nowadays this subgroup is rising. In this study, we compared the composition of faecal microbiota, Short Chain Fatty Acids (SCFAs), and systemic biomarkers between elderly HIV-positive and HIV-negative subjects. Methods A cross-sectional study with 18 HIV-negative controls and 20 HIV-positive patients. The quantification of Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Lactobacillus, Enterobacteriaceae, Bifidobacterium, Escherichia coli, Clostridium leptum, Clostridium coccoides was performed in faecal samples by qPCR. The analysis was performed by calculating the ΔCq of each microorganism using 16S rDNA as a reference gene. Faecal SCFAs were measured by HPLC. The hs-CRP and sCD14 were performed by ELISA. Results An increase in the Firmicutes/Bacteroidetes ratio, coupled with a significant increase in the proteobacteria phylum was detected in HIV-positive subjects. In contrast, a decrease in the Clostridium leptum group was observed. Nevertheless, these elderly HIV-positive patients showed higher levels of total SCFAs mainly by an augmented propionic acid values, compared to HIV-negative subjects. Whereas high levels of hs-CRP were positively correlated with sCD14 in the HIV-positive group. Conclusions Alterations in bacterial communities reveals a dysbiotic state related to an unbalance of faecal SCFAs. Therefore, these intestinal conditions might drive an increase of poor prognostic biomarkers in elderly HIV-positive subjects.

Gut Microbiota Dysbiotic Pattern and Its Associated Factors in a Cameroonian Cohort with and without HIV Infection

“…Also, reports on lower counts of Lactobacillus [29] and Bifidobacterium were shown in the stool of HIV-treatment naïve individuals [30]. Previous works have linked the depletion of Bifidobacterium and Lactobacillus during HIV infection and their effects in gut barrier destruction and poor immune function in the GALT [31]. Our study suggests that there is an association between depletion of protective Lactobacillus and bifidobacteria, and enrichment of pathobionts fusobacteria and Candida.…”

The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation

“…Furthermore, in PLWH, there is a lower abundance of butyrate-producing bacteria (105,106). Butyrate plays an important role as an energy source for colonic epithelial cells and epithelial barrier integrity, T-cell activation, colonic regulatory T cell differentiation, gut and blood antigen presenting cell (APC) modulation (105)(106)(107)(108)(109). Lower abundance of butyrate-producing bacteria has been associated with poor clinical outcome in Crohn's disease, ulcerative colitis and colon cancer (110,111).…”

Metformin effect on gut microbiota: insights for HIV-related inflammation

“…Furthermore, gut dysbiosis correlated with plasma kynurenine levels in ART-treated PLWH [73]. In addition, a decreased abundance of bacteria producing the gut epithelial protector butyrate, including Roseburia, Coprococcus, Faecalibacterium, and Eubacterium, was observed in both HIV-treated and ART-naïve individuals, in association with altered SCFAs profiles [80,81]. Finally, HIV infection is associated with increased risk of coronary heart disease beyond that explained by traditional risk factors, and altered gut microbiota has been proposed as a key contributing determinant [82].…”

“…In PLWH, there is a lower abundance of butyrate-producing bacteria in the gut microbiota [80,81]. Interestingly, metformin was shown to increase the abundance of butyrate producing bacteria in both diabetic and healthy individuals [27,60].…”